NCT00212381View on ClinicalTrials.gov

Oral Diindolylmethane (DIM) for the Treatment of Cervical Dysplasia

PHASE3CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

September 30, 2000

Primary Completion Date

January 31, 2006

Study Completion Date

July 31, 2010

Conditions
Cervical Dysplasia
Interventions
DRUG

di indolylmethane (DIM)

This is the agent being studies. Similar agents have been reported to have potential activity.

DIETARY_SUPPLEMENT

Red rice bran

"this will act as the active comparator. The sponsor provided this as the placebo arm since it is a filler component of their DIM capsules"

Trial Locations (1)

10016

NYU School of Medicine, New York

All Listed Sponsors
lead

New York Presbyterian Hospital

OTHER

NCT00212381 - Oral Diindolylmethane (DIM) for the Treatment of Cervical Dysplasia | Biotech Hunter | Biotech Hunter